Role of Transrectal Doppler Ultrasound in Assessing Bladder Outlet Obstruction View PDF

*Shady Emara
Department Of Reconstructive Urology, Western General Hospital, Edinburgh, Scotland, United Kingdom

*Corresponding Author:
Shady Emara
Department Of Reconstructive Urology, Western General Hospital, Edinburgh, Scotland, United Kingdom
Email:shady.emara@nhs.net

Published on: 2019-11-25

Abstract

Objective: Assessing the role of Transrectal Doppler Ultrasound in estimating degree of bladder outlet obstruction, in patients with benign prostatic hyperplasia.
Methods: Fifty-two patients aged from 55 to 70 with the clinical diagnosis of Benign Prostatic Hyperplasia (BPH) were recruited. Patients with cancer prostate, neurogenic bladder, previous lower urinary tract intervention, were excluded. Urologic evaluation included, thorough history, International Prostate Symptom Score (IPSS), neurologic examination, digital rectal examination, urine analysis, PSA, uroflowmetry, transrectal doppler ultrasonography. The correlations were analysed between the resistive index of prostatic capsular artery, and maximum flow rate (Qmax).
Results: A significant increase in RI correlated to decrease in Qmax (r=0.398, p<0.016) was found. Also there was significant increase in RI correlated to increase in IPSS (r=0.535, p<0.001). As regards Qmax, there was significant decrease in Qmax correlated to increase in IPSS (r=-0.654, p<0.001).
Conclusion: Transrectal Doppler can be used as a tool to measure degree of bladder outlet obstruction, through measuring resistive index of prostatic capsular artery.

Keywords

Transrectal Doppler Ultrasound; Arterial resistivity index; Doppler imaging

Introduction

Arterial resistivity index (also called a Resistive index, abbreviated as RI), developed by Leandre Pourcelot, in 1982. It is a measure of pulsatile blood flow that reflects the resistance to blood flow caused by microvascular bed distal to the site of measurement [1].

Owing to the advent of Doppler imaging, RI measurement in patients with LUTS has become a promising parameter for the diagnosis of BPH. It was found that a hyperplastic prostate tissue pushed the capsule out as it grew thus increasing the intraprostatic pressure as well as RI. The increase of the intraprostatic pressure is equally distributed throughout the whole prostate, so the increase of RI was found in both peripheral and transition zones [1].

Also, as regard PDUS, the technique has been found to enhance prostate cancer detection. Spectral waveform measurements by power Doppler TRUS may be promising for the differentiation of PCa in patients with benign diseases as an adjunct to systematic sampling in the presence of ultrasonographically detectable lesions accompanied by positive rectal examination findings and suspicious PSA levels [2].

Resistive index of prostatic capsular artery for evaluating obstruction.It was used for the first time by Kojima and his colleagues in the differentiation of the normal prostate in BPH patients [1].

How BPH increases RI of prostatic capsular artery?

How prostatic RI increases in BPH patients, is stillnot completely understood, may be the hypertrophied prostate squeezes the capsule outwards, which results in an increase in intraprostatic pressure and prostatic R I[3].

Supporting Evidence

This is supported by the decrease in RI value after a prostatectomy [1]. Doxazosin treatment significantly decreased prostatic RI in BPH patients [4]. It was shown that the RI increases significantly correlated to the increase in prostatic volume, and that there was a significant difference in RI between patients with normal prostate and those with BPH [1]. Which branch of prostatic artery to measure RI and which zone?

An increase of the RI of capsular arteries correlated with prostatic parameters in patients with BPH, however, no correlation between the RI of urethral arteries and prostatic parameters was found. The findings suggested that the RI of capsular arteries may become the index for measuring lower urinary obstruction in the future [5].

How is RI measured?

The indices depend on ratios involving the peak systolic velocity (PSV), the end diastolic velocity (EDV) and mean velocity (MV) through one cycle. RI is one of the primary indices used clinically and is calculated through the following equation [1].

  • RI = PSV-EDV

PSV - Where the normal value according to Kojima, et al 0.55-0.71 [6].

  • Power Doppler vs. color Doppler

The weak points include it is hypothesized that an enlargement of the median lobe may not impact RI value as it does not impose increased resistance to capsular arteries. The association of intravesical prostatic protrusion (IPP) could add for a more precise diagnosis in this scenario [1].

Patients and Methods

This study was conducted on 52 patients presenting with LUTS due to BPH, to the outpatient clinic at Kasr Al-Aini University Hospital, Mansoura Urology and Nephrology Centre, and The National Institute of Urology and Nephrology.

Patients

The inclusion criteria include patients aged from 55 to 70 years presenting with LUTS due to BPH.

The exclusion criteriainclude patients who had one or more of the following were excluded from the study: Patients with prostate cancer (In cases of abnormal PSA, or abnormalDRE, TRUS biopsy was done to exclude cancer).

Patients with history of lower urinary tract interventions and patients with neurogenic bladder(Based on history, clinical examination, and post voiding residual volumes).

Methods

All patients were subjected thorough history taking.

Full history was taken from all cases about:

  • Personal history: This included age, occupation, special habits of medical importance and sexual history.
  • Previous history: Surgical history: previous lower urinary tract interventions.
  • Medical history: Diabetes Mellitus, Hypertension, and neurogenic disorders.
  • Family history: Cancer prostate
  • Presenting complaint: All patients had a self-administered, validated Arabic version of IPSS questionnaire.
  • Clinical examination: Each patient was thoroughly undergone for full clinical examination.
  • General examination: It was done in all patients with including neurologic examination.
  • Genitourinary examination: Digital rectal examination was done to every patient to assess prostate size, surface, and consistency, and assessing anal tone, or as a part of bulbocavernosus reflex test.
  • Lab examination: For urine analysis, culture and PSA (free and total).
  • Uroflowmetry: It was done to assess the urine flow and measure the Qmax. Cases in which detrusorhypo contractility was suspected (due to neurogenic insult, diabetes or very old age>70), were omitted.
  • Transrectal Ultrasonography and doppler: To measure size of prostate, adenoma, residual volume. Doppler was used to measure resistive index of prostatic capsular artery. The machine used is BK medical flex 400.
  • Statistical analysis: Data were collected, verified, revised then edited on personal computer.Categorical variables were expressed as absolute and relative frequencies while continuous variables were presented as mean values±standard deviation (SD).Comparisons were made between continuous and ordinal variable using student t test, comparisons were made between 2 continuous variables using Pearson’s correlation.Sensitivity and Specificity was calculated using chi-square test.Statistical analysis was performed using SPSS (statistical package version sixteen).Difference was considered statistically significant at a P value<0.05 and highly significant at P value<0.01.

Results

Number of patients enrolled in this study was 52 patients. Range of age was 55-70 with mean age 63.8±4.6. Eight parameters were studied, and the values of these studies were summarized in table (Table 1).

Table 1: Summary of results.

Descriptive Statistics

 

Range

Mean ± SD

Age (year)

55-70

63.863 ± 4.643

IPSS

1-35

19.882 ± 9.361

Qmax (ml/sec)

2.6-17.9

9.097 ± 4.591

PSA (ng/ml)

0.9-33

10.903 ± 8.776

Total gland volume (gm)

20-295

82.922 ± 45.808

Adenoma (gm)

9-202

51.524 ±35.149

Residual urine (ml)

0-450

77.030 ± 96.311

RI

0.29-0.95

0.728 ± 0.110

The mean patients’ age was 63.86 years, the mean IPSS was 19.88, the mean Qmax was 9.09 ml/sec, the mean PSA was 10.9 ng/ml, the mean total gland volume was 82.92 gm, the mean adenoma volume was 51.52 gm, the mean residual urine volume was 77.03 ml, the mean resistive index was 0.73.

Mean resistive index for obstructed group was 0.76, while for the non-obstructed group was 0.69. Normal RI of prostatic capsular artery is 0.55-0.71 [6] (Table 2).

Table 2: Correlation between Qmax and other factors in question for being indicator of degree of obstruction.

Correlations

 

Qmax

r

P-value

Age

-0.017

0.923

IPSS

-0.654

<0.001*

PSA

0.013

0.955

P. Size

-0.111

0.519

Adenoma

-0.028

0.886

Residual V

-0.201

0.269

The only statistical significance was found in correlation between Qmax and IPSS (r=-0.654, p<0.001).

No statistical significance was found in correlation between Qmax and age (r=-0.017, p=0.923), no statistical significance was found in correlation between Qmax and PSA (r=0.013, p=0.955), no statistical significance was found in correlation between Qmax and prostate size (r=-0.111, p=0.519), no statistical significance was found in correlation between Qmax and adenoma volume (r=-0.028 , p=0.866), no statistical significance was found in correlation between Qmax and residual volume of urine (r=-0.201, p=0.269) ( Figure 1) (Table 3).

Table 3: Correlation between RI, Qmax and other factors in question for being indicator of degree of obstruction.

Correlations

 

RI

r

P-value

Qmax

-0.398

0.016*

Age

0.008

0.954

IPSS

0.535

<0.001*

PSA

-0.166

0.347

P Size

0.023

0.875

Adenoma

0.071

0.656

Residual V

0.243

0.173

Statistical significance was found in correlation between RI and Qmax (r=-0.398, p=0.016), and between RI and IPSS (r=-0.398, p=0.016) (Figure 2) (Table 4).

Table 4: Range of resistive index of capsular prostatic artery for each group of IPSS.

Group

Number of

patients

Minimum

resistive index

Maximum

resistive index

Mild

4

0.29

0.67

Moderate

21

0.55

0.89

Severe

27

0.61

0.95

The patients were divided according to IPSS as follows: mild symptoms (0-7), moderate symptoms (8-19), and severe symptoms (20-35) groups. In the mild symptoms group RI ranged from 0.29 to 0.67, in the moderate symptoms group RI ranged from 0.55 to 0.89, in the severe symptoms group RI ranged from 0.61 to 0.95 (Figure 3).

  • Sensitivity and specificity of RI: Positivity of the test was assumed to be RI>0.71 (the upper limit of RI of normal prostatic capsular artery from Kojima study).

The diseased group was assumed to be those with Qmax<10 ml/sec. (according to cut off established by Nitti et al 90% of men with a Qmax of less than 10 mL/sec are obstructed) (Table 5).

Table 5: Calculating sensitivity, specificity, PPV, and NPV of RI of prostatic capsular artery.

 

Diseased (obstructed, Qmax<10ml/sec)

Non-diseased

(not obstructed, Qmax ≥ 10ml/sec)

Total

+ve (RI>0.71)

20

6

26

-ve (RI≤ 0.71)

8

18

26

Total

28

24

52

26 patients had resistive index more than 0.71, 20 of them were truly obstructed i.e. Qmax less than 10 ml/sec, and 6 of them were not obstructed, i.e. Qmax more than 10 ml/sec. On the other side there were also 26 patients whose resistive index was less than or equal 0.71, 18 of them were not obstructed Qmax more than 10 ml/sec, but there was 8 obstructed Qmax less than 10 ml/sec (Table 6).

Table 6: Sensitivity, specificity, PPV, and NPV of RI of prostatic capsular artery at different resistive indices.

RI

Sensitivity

Specificity

PPV

NPV

0.75

57

89

88

60

0.8

38

100

100

54

0.85

27

100

100

50

  • Sensitivity=71% PPV=77%
  • Specificity=75% NPV=69%

At RI 0.75,

  • Sensitivity=57% PPV=88%
  • Specificity=89% NPV=60%

At RI 0.8,

  • Sensitivity=38% PPV=100%
  • Specificity=100%NPV=54%

At RI 0.85,

  • Sensitivity=27% PPV=100%

Specificity=100% NPV=50%

Discussion

Thanks to doppler imaging invention RI measurement in patients with LUTS has become a promising parameter for the diagnosis of BPH. It was found that a hyperplastic prostate tissue pushed the capsule out as it grew thus increasing the intraprostatic pressure as well as RI. The increase of the intraprostatic pressure is equally distributed throughout the whole prostate, so the increase of RI was found in both peripheral and transition zones.

In a Turkish study, the authors have intervened with Afluzosin XL 10 mg given to 34 patients with LUTSs for a month. They have found significant relationship between RI, Qmax, IPSS, and PSA. The mean RI value was 0.72+0.06 before medication and decreased significantly to 0.66+0.04 after the treatment (p<0.05). There was no relationship between RI and age (r=0.23, p>0.05). This study also depended on uroflowmetry rather than urodynamics [7].

In a study by Kojima M and colleges, they investigated the relationship between the resistive index (RI) of the prostate as measured by transrectal power Doppler with age, transrectal ultrasound planimetry and parameters of pressure-flow study.A total of 140 elderly patients with lower urinary tract symptoms and no previous treatment for lower urinary tract symptoms, prostate cancer, bladder dysfunction or urethral stricture were investigated. A mean RI of 0.72 ± 0.06 (range 0.59-0.88) was measured in patients with BPH versus a mean value of 0.64±0.04 (range 0.55-0.71) in those with a normal prostate (P<0.0001). The strongest correlation was found between RI and Pdet (r=0.401, P<0.005), followed by PdetQmax (r=0.360, P<0.01) and the Abrams-Griffiths number (r=0.330, P<0.05). This study depended on urodynamics to obtain the Pdet, thus bladder outlet obstruction index BOOI could be calculated and correlated with the RI. On the other side, the authors didn't mention IPSS as one of parameters for judging degree of bladder outlet obstruction [6].

The reason for the increase in RI in BPH has not been established, but it may be because the growing hypertrophic prostate pushes the capsule outward and thereby increases intraprostatic pressure and RIs [8].

In our study, 28 patients out of 52 (54%) were diagnosed obstructed i.e., Qmax less than 10 ml/sec, 21 (40%) patients were equivocal i.e. Qmax 10-15 ml/sec, and 3 patients (6%) were not obstructed i.e., Qmax more than 15 ml/sec.

We have correlated between the resistive index, Qmax, IPSS, PSA, age, prostate volume, and adenoma volume. There was a significant increase in RI correlated to decrease in Qmax (r=-0.398, p<0.016). Also there was significant increase in RI correlated to increase in IPSS (r=0.535, p<0.001). AS regard Qmax, there was significant decrease in Qmax correlated to increase in IPSS (r=-0.654, p<0.001).

Conversely, no relation was found between degree of obstruction and other parameters; age, PSA, prostate volume, adenoma volume, residual volume.

At a cut off 0.71 the resistive index distinguished patients with and without bladder outlet obstruction with 71% sensitivity and 75% specificity, reflecting BOO severity in patients with BPH. At cut off of 0.8, RI is highly specific 100%, so it can strongly confirm the diagnosis of obstruction.

Our results are consistent with those of Zhang X et al. 2012, at nearly equal resistive index (0.71 in our study and 0.69 in Zhang study), the resistive index had sensitivity 71% compared to 78% in Zhang study. While specificity was 75% in our study, it was 86% in Zhang study.

The value of measuring the prostatic resistive index vs. pressure-flow studies in the diagnosis of bladder outlet obstruction caused by benign prostatic hyperplasia:

TRUS is less invasive, cheaper and less time-consuming than pressure flow study, and measures prostatic size, which is useful in planning management [9].

Spectral waveform measurements by power Doppler transrectal ultrasonography may be useful in differentiating prostate cancer from benign hypertrophy [2].

One point of criticism was that we used uroflowmetry instead of urodynamics for assessing bladder outlet obstruction. However, we obviated cases that may have detrusorhypercontractility by excluding patients older than 70 years, excluding patients with suspected neurogenic element, and patients with very large residual volumes suggesting chronic retention.

Comparing the results of our study with those of other studies mean age and mean prostatic volume (Tables 7 and 8).

Table 7: Comparing patient age in different studies.

Study

Mean age (years)

Our study

63.9

Osama et al. 2012

66.8

Hitoshi et al. 2009

71.1

Zhang X et al. 2012

67.5

Table 8: Comparing prostate volume in different studies.

Study

Mean prostatic volume (grams)

Our study

82.9

Osama et al. 2012

75.1

Hitoshi et al. 2009

71.6

Zhang X et al. 2012

53.5

 

Limitations of the Study

When comparing values of RIs between IPSS groups (mild, moderate, severe), there was overlap between groups, i.e. some patients with mild symptoms had higher RI than some patients with moderate symptoms, and some patients with moderate symptoms had higher RI than somepatients with severe symptoms, we attribute this overlap to the following:

Cases with only enlarged median lobe. It is hypothesized that an enlargement of the median lobe may not impact RI value as it does not impose increased resistance to capsular arteries. The association of intravesical prostatic protrusion (IPP) could add for a more precise diagnosis in this scenario [1].

There is some sort of selection bias. This group of age (55-70) mostly, will have cardiovascular risk factors placing further burdens on their prostatic blood flow. Prostate RI values are highly linked to overall metabolic syndrome and smoking in addition to BPH [10]. So, we recommend a study upon younger population in conjunction with cardiologists for assessing cardiovascular risk factors, thus excluding all factors than can influence RI other than pathology of BPH.

IPSS questionnaire is sometimes a difficult task for the patient, and they tend to just complete it carelessly, this is due to many factors: poor vision in old age (which is the case of most patients with BPH), low level of education, or lack of interest.

Conclusion

RI can be used as a modality for assessing BPH patients and anticipating success of surgery.RI is a good indicator for degree of bladder outlet obstruction due to BPH, rather than other parameters as prostate volume, adenoma volume, residual volume, and PSA.Further research in this field will even allow the use of this modality to investigate other pathologies affecting the prostate and can be used also to evaluate the outcome of management.

Recommendation

We recommend a study upon younger population in conjunction with cardiologists for assessing cardiovascular risk factors like atherosclerosis,hyperlipidaemia, and smoking. Thus excluding all factors than can influence RI other than pathology of BPH. Further studies in larger cohorts are required to validate the reliability of prostate capsular artery RI.

References

  1. Abdelwahab O, El-Barky E, Khalil MM, Kamar A (2012) Evaluation of the resistive index of prostatic blood flow in benign prostatic hyperplasia. Int Braz J Urol 38: 250-257.
  2. Turgut AT, Ölçücüo?lu E, Ko?ar P, Geyik PÖ, Ko?ar U, et al. (2007) Power doppler ultrasonography of the feeding arteries of the prostate gland. J Ultrasound Med 26: 875-883.
  3. Yencilek E, Koyuncu H, Arslan D, Bastug Y (2014) The measurement of the prostatic Resistive Index is a reliable ultrasonographic tool to stratify symptoms of patients with benign prostatic hyperplasia. Med Ultrason 16: 208-213.
  4. Özden C, Günay ?, Deren T, Bulut S, Koparal S, et al. (2009) Effect of Doxazosin on prostatic resistive index in patients with benign prostate hyperplasia. F?rat T?p Dergisi 14: 171-174.
  5. Tsuru N, Kurita Y, Masuda H, Suzuki K, Fujita K (2002) Role of Doppler ultrasound and resistive index in benign prostatic hypertrophy. Int J Urol 9: 427-430.
  6. Kojima M, Ochiai A, Naya Y, Okihara K, Ukimura O, et al. (2000) Doppler resistive index in benign prostatic hyperplasia: correlation with ultrasonic appearance of the prostate and infravesical obstruction. Eur Urol 37: 436-442.
  7. Karakose A, Alp T, Guner ND, Aras B, Ayd?n S (2010) The role of Doppler ultrasonography and resistive index in the diagnosis and treatment of benign prostate hyperplasia. Turk J Urol 36: 292-297.
  8. Kwon SY, Ryu JW, Choi DH, Lee KS (2016) Clinical significance of the resistive index of prostatic blood flow according to prostate size in benign prostatic hyperplasia. Int Neurourol J 20: 75-80.
  9. Aldaqadossi HA, Elgamal SA, Saad M (2012) The value of measuring the prostatic resistive index vs. pressure-flow studies in the diagnosis of bladder outlet obstruction caused by benign prostatic hyperplasia. Arab J Urol 10: 186-191.
  10. Baykam MM, Aktas BK, Bulut S, Ozden C, Deren T, et al. (2015) Association between prostatic resistive index and cardiovascular risk factors in patients with benign prostatic hyperplasia. Kaohsiung J Med Sci 31: 194-198.
scroll up